Expert Consensus Statement on Transcatheter Aortic Valve Replacement

A new tool to support clinical decision making

Sponsoring Organization: American College of Cardiology (ACC)

Target Audience: Primary care providers; general and interventional cardiologists; cardiovascular radiologists, surgeons, and care coordinators; anesthesiologists

Target Population: Adults with severe aortic stenosis

Background and Objective

This Expert Consensus Decision Pathway was developed to provide clinicians with practical information, point-of-care checklists, and decision algorithms for the use of transcatheter aortic valve replacement (TAVR) in adults with severe, symptomatic valvular aortic stenosis (AS). The document builds on the revised 2014 Clinical Practice Guideline for the management of valvular heart disease (NEJM JW Cardiol Jun 2014 and J Am Coll Cardiol 2014; 63:…

Reviewing Author

Howard C. Herrmann, MD

Disclosures

Consultant/Advisory BoardAffluent Medical; Artedrone; Caranx; Johnson & Johnson; Medtronic; Prolifagen; Wells Fargo

EquityMicrointerventional Devices, Inc.

RoyaltiesUniversity of Pennsylvania

Grant/Research SupportAbbott Vascular; Edwards Lifesciences; Johnson & Johnson; Medtronic

Editorial BoardsCatheterization and Cardiovascular Interventions; Journal of the American College of Cardiology; Circulation: Cardiovascular Interventions; JACC Cardiovascular Interventions; JACC Case Reports; JSCAI

Leadership Positions in Professional SocietiesHeart Valve Collaboratory (Scientific Committee Member, Chair of the Publications Committee)